LOBO Vascular Occlusion System
Commercial- Indications
- peripheral vascular occlusion
Company intelligence / Profile preview
Okami Medical has developed and commercialized the LOBO Vascular Occlusion System, which includes multiple sizes of high-density braided vascular occluders designed for rapid and complete vessel closure. The system has received FDA 510(k) clearance for several product variants, demonstrating fast time to vessel occlusion with a single device. Clinical feedback highlights improved efficiency and life-saving potential in trauma cases.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Okami Medical.